197 related articles for article (PubMed ID: 31183806)
1. Nasal Cavity Administration of Melanin-Concentrating Hormone Improves Memory Impairment in Memory-Impaired and Alzheimer's Disease Mouse Models.
Oh ST; Liu QF; Jeong HJ; Lee S; Samidurai M; Jo J; Pak SC; Park HJ; Kim J; Jeon S
Mol Neurobiol; 2019 Dec; 56(12):8076-8086. PubMed ID: 31183806
[TBL] [Abstract][Full Text] [Related]
2. Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson's Disease.
Park JY; Kim SN; Yoo J; Jang J; Lee A; Oh JY; Kim H; Oh ST; Park SU; Kim J; Park HJ; Jeon S
Mol Neurobiol; 2017 Dec; 54(10):7706-7721. PubMed ID: 27844281
[TBL] [Abstract][Full Text] [Related]
3. AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang X; Zhao F; Wang C; Zhang J; Bai Y; Zhou F; Wang Z; Wu M; Yang W; Guo J; Qi J
Neurosci Bull; 2020 Mar; 36(3):254-262. PubMed ID: 31605298
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletion of melanin-concentrating hormone neurons impairs hippocampal short-term synaptic plasticity and hippocampal-dependent forms of short-term memory.
Le Barillier L; Léger L; Luppi PH; Fort P; Malleret G; Salin PA
Hippocampus; 2015 Nov; 25(11):1361-73. PubMed ID: 25808129
[TBL] [Abstract][Full Text] [Related]
5. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
6. Melanin-Concentrating Hormone acts through hypothalamic kappa opioid system and p70S6K to stimulate acute food intake.
Romero-Picó A; Sanchez-Rebordelo E; Imbernon M; González-Touceda D; Folgueira C; Senra A; Fernø J; Blouet C; Cabrera R; van Gestel M; Adan RA; López M; Maldonado R; Nogueiras R; Diéguez C
Neuropharmacology; 2018 Mar; 130():62-70. PubMed ID: 29191753
[TBL] [Abstract][Full Text] [Related]
7. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
8. Melanin-concentrating hormone (MCH) modifies memory retention in rats.
Monzon ME; de Souza MM; Izquierdo LA; Izquierdo I; Barros DM; de Barioglio SR
Peptides; 1999 Dec; 20(12):1517-9. PubMed ID: 10698129
[TBL] [Abstract][Full Text] [Related]
9. Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
Jürgenson M; Zharkovskaja T; Noortoots A; Morozova M; Beniashvili A; Zapolski M; Zharkovsky A
J Pharm Pharmacol; 2019 Nov; 71(11):1695-1705. PubMed ID: 31531878
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
11. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation.
Liu HL; Zhao G; Cai K; Zhao HH; Shi LD
Behav Brain Res; 2011 Apr; 218(2):308-14. PubMed ID: 21192984
[TBL] [Abstract][Full Text] [Related]
12. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
13. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
14. Central administration of melanin-concentrating hormone increases alcohol and sucrose/quinine intake in rats.
Duncan EA; Proulx K; Woods SC
Alcohol Clin Exp Res; 2005 Jun; 29(6):958-64. PubMed ID: 15976521
[TBL] [Abstract][Full Text] [Related]
15. WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration.
Wang Z; Cao M; Xiang H; Wang W; Feng X; Yang X
ACS Chem Neurosci; 2019 Dec; 10(12):4787-4799. PubMed ID: 31697472
[TBL] [Abstract][Full Text] [Related]
16. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
17. Novel analgesic effects of melanin-concentrating hormone on persistent neuropathic and inflammatory pain in mice.
Jang JH; Park JY; Oh JY; Bae SJ; Jang H; Jeon S; Kim J; Park HJ
Sci Rep; 2018 Jan; 8(1):707. PubMed ID: 29335480
[TBL] [Abstract][Full Text] [Related]
18. Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice.
Smith DG; Davis RJ; Rorick-Kehn L; Morin M; Witkin JM; McKinzie DL; Nomikos GG; Gehlert DR
Neuropsychopharmacology; 2006 Jun; 31(6):1135-45. PubMed ID: 16205780
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
